Ultragenyx Pharmaceutical Inc. 8-K Report: Key Insights & Updates
Based on the provided section of the financial report, here are the key insights and important information extracted:
- Entity Information:
- Company Name: Ultragenyx Pharmaceutical Inc.
- CIK (Central Index Key): 0001515673
- SEC File Number: 001-36276
- EIN (Employer Identification Number): 27-2546083
- Address: 60 Leveroni Court, Novato, CA 94949
- Phone Number: 415-483-8800
- Reporting Type:
- Form Type: 8-K, which is used to report unscheduled material events or corporate changes that are of importance to shareholders.
- Reporting Date:
- Date of Report: January 12, 2025
- Security Information:
- Type of Security: Common Stock
- Par Value: $0.001
- Stock Symbol: RARE
- Exchange: NASDAQ
- Context Information:
- Period Covered: The report covers the date January 12, 2025, indicating it may relate to a specific event or condition as of that date.
This information is useful for understanding the company’s current status and any significant events that may impact its financial standing or operations as reported in the 8-K filing.